Evidence map›Paper›PMID 27250711›Full record

ArticleJournal of neuroinflammation2016

Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination.

Hyun Seok Kang, Jinjong Myoung, Eui Young So, Young Yil Bahk, Byung S Kim

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Rapid Expansion of Virus-Specific CD4International journal of molecular sciences · 2020
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Hyun Seok KangDepartment of Microbiology-Immunology, Northwestern University Medical School, 303 East Chicago Ave., Chicago, IL, 60611, USA.
Jinjong MyoungDepartment of Microbiology-Immunology, Northwestern University Medical School, 303 East Chicago Ave., Chicago, IL, 60611, USA.
Eui Young SoDepartment of Microbiology-Immunology, Northwestern University Medical School, 303 East Chicago Ave., Chicago, IL, 60611, USA.
Young Yil BahkDepartment of Microbiology-Immunology, Northwestern University Medical School, 303 East Chicago Ave., Chicago, IL, 60611, USA.
Byung S KimDepartment of Microbiology-Immunology, Northwestern University Medical School, 303 East Chicago Ave., Chicago, IL, 60611, USA. bskim@northwestern.edu.
Northwestern University · USJeonbuk National University · KR

Funding

T-CELL RECEPTORS INVOLVED IN TMEV-INDUCED DEMYELINATIONR01NS033008 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KIM, BYUNG S · 1994 to 2008
$2.5M
PATHOGENIC MECHANISMS OF TMEV INDUCED DEMYELINATIONR01NS028752 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KIM, BYUNG S · 1990 to 2008
$2.1M
NINDS NIH HHS R01 NS028752NINDS NIH HHS R01 NS033008
6 · The paper itself

Abstract

backgroundChronic infection with Theiler's murine encephalomyelitis virus (TMEV) in susceptible SJL/J mice induces an immune-mediated demyelinating disease and has extensively been used as a relevant infectious model for multiple sclerosis (MS). Infection of the host with many other viruses also leads to acute or chronic inflammatory diseases in the central nervous system (CNS). Levels of viral load in the host often play a critical role in the pathogenesis of virus-induced diseases. Thus, the inhibition of viral replication in the host against a broad spectrum of similar viruses is critically important for preventing the viral pathogenicity.

methodsP2/P3-expressing transgenic (B6 X SJL)F1 founders were generated and bred onto the C57BL/6 and SJL/J backgrounds. Differences in the development of demyelinating disease were compared. Viral persistence, cytokine production, and immune responses in the CNS of infected control and P2/P3-Tg mice were analyzed after infection using quantitative PCR, ELISA, and flow cytometry. Various cell types from the control and P2/P3-Tg mice, as well as cells transfected in vitro with the P2 and/or P3 regions, were also analyzed for viral replication and innate cytokine production.

resultsP2/P3-transgenic (P2/P3-Tg) mice carrying the viral non-structural protein genes displayed significantly reduced virus-specific T cell responses in the CNS against both the structural and non-structural proteins. Consequently, viral loads in the CNS were greater in the Tg mice during the chronic infection. However, P2/P3-Tg SJL mice exhibited reduced disease incidence and less severe clinical symptoms than did their non-transgenic littermates. Interestingly, P2/P3-Tg mice showed low viral loads in the CNS at a very early period after infection (1-3 days) with TMEV and related EMCV but not unrelated VSV. Cells from P2/P3-Tg mice and cells transfected with the P2 and/or P3 regions in vitro yielded also lower viral replication but higher IFN-α/β production.

conclusionsThis study demonstrates that the expression of viral non-structural genes in mice inhibits initial viral replication and suppresses sustaining pathogenic anti-viral immune responses to broad viral determinants. It appears that the elevation of innate immune cytokines produced in the cells expressing the non-structural viral genes upon viral infection is responsible for the inhibitions. The inhibition is partially virus-specific as it is more efficient for a related virus compared to an unrelated virus, suggesting a role for the similarity in the viral genome structures. Therefore, the expression of viral non-structural genes may serve as a useful new method to prevent a broadly virus-specific pathogenesis in the hosts.

Indexed as

Gene Expression Regulation, ViralAnimalsCells, CulturedDemyelinating DiseasesFemaleMiceMice, Inbred C57BLMice, TransgenicTheilovirusT-LymphocytesVirus ReplicationCNSP2/P3 transgenic micePathogenesisT cellsTMEV

Identifiers

PMID27250711
PMCPMC4888636
OpenAlexW2409187293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.